HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCW Biologics is trading 8.88% down in pre-market after a $1.5 million private placement
HCW Biologics is trading at $1.81, down 8.88%, after announcing a $1.5 million private placement on September 24, 2026. - The financing includes 903,614...
🔴 HCW Biologics is trading 6.5% down in after-hours trading after a $1.5 million private placement announcement
HCW Biologics is trading 6.5% down at $1.86 after announcing a $1.5 million private placement, which may be prompting after-hours reassessment following its...
HCW Biologics Surges 43% on a Tiny $1.5 Million Deal — Is This a Lifeline or a Last Resort?
Shares of HCW Biologics rocketed 43.4% to $2.38 on September 24 after the micro-cap biotech priced a $1.5 million private placement with an existing...
🟢 HCW Biologics is trading 43.37% up today after pricing a $1.5 million private placement
HCW Biologics is trading 43.37% up at $2.38 after announcing pricing for a $1.5 million private placement with an existing stockholder. - The financing...
🟢 HCW Biologics is trading 6.33% up today amid a $1.5 million private placement announcement
HCW Biologics is trading 6.33% higher at $1.76 amid its announcement of a $1.5 million private placement; the announcement did not explicitly attribute the...
🟢 HCW Biologics is trading 5.42% up in pre-market
HCW Biologics is trading 5.42% higher at $1.75 in pre-market, with no new company-specific announcement identified to explain the rebound. - Shares closed at...
🟢 HCW Biologics is trading 5.42% up in after-hours trading
HCW Biologics is trading at $1.75, up 5.42% in after-hours trading, with no clear company-specific catalyst identified for the rebound. - Shares closed the...
🔴 HCW Biologics is trading 10.5% down today amid higher oil prices and Treasury yields
HCW Biologics is trading 10.5% lower at $1.62 amid a broader market retreat linked to higher oil prices, Treasury yields and cautious risk sentiment. - No...
🔴 HCW Biologics is trading 5.8% down today on higher oil prices and Treasury yields
HCW Biologics is trading 5.8% down at $1.71, with broader market pressure the likeliest explanation. - No fresh company-specific catalyst was identified; the...
🟢 HCW Biologics rises 5.5% — Biotech Sector Surges in Pre-Market on Multiple Positive News Snippets
With Biotech (XBI) up 2.6%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 HCW Biologics is trading 6.81% down today
HCW Biologics is trading at $1.78, down 6.81%, with the specific catalyst unidentified. - No new company-specific announcement dated September 22, 2026 was...
🟢 HCW Biologics is trading 8% up today as S&P 500 and Nasdaq rise
HCW Biologics is trading at $2.02, up 8.02%, with the move aligned with broader risk-on market sentiment. - The S&P 500 and Nasdaq are both higher than...
🟢 HCW Biologics is trading 10.16% up in pre-market on broader risk-on sentiment
HCW Biologics is trading at $2.06, up +10.16% in pre-market, with broader risk-on sentiment the clearest explanation. - No new company-specific announcement...
🟢 HCW Biologics is trading 6.95% up in pre-market as major U.S. indexes rise
HCW Biologics is trading at $2.00, up 6.95%, alongside a broadly stronger pre-market, with major U.S. indexes up more than 0.5%. - No new company-specific...
🟢 HCW Biologics is trading 6.67% up today in after-hours trading as XBI gains 2.55%
HCW Biologics is trading 6.67% up at $2.08 in after-hours trading after broader biotech-sector strength, with the XBI ETF gaining 2.55% on September 18,...
🟢 HCW Biologics is trading 6.67% up today amid stronger biotech-sector sentiment
HCW Biologics is trading at $2.08, up 6.67%, amid stronger biotech-sector sentiment. - Biotech ETF XBI is up 2.55%, supporting sector-wide risk appetite. - No...
🟢 HCW Biologics is trading 6.67% up in after-hours trading amid broad risk-on sentiment
HCW Biologics is trading at $2.08 with a +6.67% change in after-hours trading, appearing aligned with broad risk-on sentiment. • No new company-specific...
🟢 HCW Biologics is trading 8.91% up today in pre-market as broad risk-on rebound lifts U.S. equities
HCW Biologics is trading 8.91% up at $2.19 as a broad risk-on rebound lifts U.S. equities in pre-market trading. - No new company-specific announcement or...
🔴 HCW Biologics is trading 6.83% down today as XBI falls 2.11%
HCW Biologics is trading 6.83% down at $1.91, mainly amid continued biotechnology weakness, with XBI down 2.11% despite broader indexes trading higher. - No...
🟢 HCW Biologics is trading 6.01% up in after-hours trading without a confirmed catalyst
HCW Biologics is trading 6.01% up at $2.17 after-hours, without a confirmed catalyst. - It closed September 15, 2026, at $2.05 after a 6.82% regular-session...